 BRISBANE, Calif., Jan. 04, 2022 GLOBE NEWSWIRE -- Vera Therapeutics, Inc. Nasdaq: VERA, a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that Marshall Fordyce, MD, founder and CEO, will present and participate in one-on-one investor meetings at the 40th Annual J.P. Morgan Healthcare Conference taking place virtually January 10-13, 2022. 